Chairman & CEO of Medicines (MDCO) Clive Meanwell sells 13,593 shares of MDCO on 11/26/2012 at an average price of $21.02 a share.

Medicines has a market cap of $1.16 billion; its shares were traded at around $21.15 with a P/E ratio of 22.5 and P/S ratio of 2.4.

This is the annual revenues and earnings per share of MDCO over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of MDCO.

CEO Recent Trades:

• Chairman & CEO Clive Meanwell sold 13,593 shares of MDCO stock on 11/26/2012 at the average price of 21.02. Clive Meanwell owns at least 355,876 shares after this. The price of the stock has increased by 0.62% since.
• Chairman & CEO Clive Meanwell sold 13,600 shares of MDCO stock on 10/25/2012 at the average price of 23.09. Clive Meanwell owns at least 355,876 shares after this. The price of the stock has decreased by 8.4% since.
• Chairman & CEO Clive Meanwell sold 13,600 shares of MDCO stock on 09/25/2012 at the average price of 26.31. Clive Meanwell owns at least 355,876 shares after this. The price of the stock has decreased by 19.61% since.
• Chairman & CEO Clive Meanwell sold 13,600 shares of MDCO stock on 08/30/2012 at the average price of 25.33. Clive Meanwell owns at least 355,876 shares after this. The price of the stock has decreased by 16.5% since.
• Chairman & CEO Clive Meanwell sold 73,607 shares of MDCO stock on 07/02/2012 at the average price of 22.8. Clive Meanwell owns at least 355,300 shares after this. The price of the stock has decreased by 7.24% since.

CFO Recent Trades:

• President & CFO Glenn Sblendorio sold 33,989 shares of MDCO stock on 08/10/2012 at the average price of 25.13. Glenn Sblendorio owns at least 96,877 shares after this. The price of the stock has decreased by 15.84% since.
• President & CFO Glenn Sblendorio sold 25,000 shares of MDCO stock on 07/25/2012 at the average price of 25.15. Glenn Sblendorio owns at least 105,866 shares after this. The price of the stock has decreased by 15.9% since.

This is the insider trade history vs. stock price of MDCO. For the complete insider trading history of MDCO, click here.

Directors and Officers Recent Trades:

• Sr. VP & General Counsel Paul Michael Antinori sold 559 shares of MDCO stock on 09/17/2012 at the average price of 26.04. Paul Michael Antinori owns at least 53,319 shares after this. The price of the stock has decreased by 18.78% since.
• Sr. VP & General Counsel Paul Michael Antinori sold 3,000 shares of MDCO stock on 08/21/2012 at the average price of 25.25. Paul Michael Antinori owns at least 53,495 shares after this. The price of the stock has decreased by 16.24% since.
• Sr. VP & General Counsel Paul Michael Antinori sold 5,662 shares of MDCO stock on 08/15/2012 at the average price of 25.3. Paul Michael Antinori owns at least 56,495 shares after this. The price of the stock has decreased by 16.4% since.
• Sr. VP & General Counsel Paul Michael Antinori sold 4,500 shares of MDCO stock on 08/10/2012 at the average price of 25. Paul Michael Antinori owns at least 62,157 shares after this. The price of the stock has decreased by 15.4% since.
• Director Robert G. Savage sold 10,000 shares of MDCO stock on 08/06/2012 at the average price of 24.94. Robert G. Savage owns at least 26,000 shares after this. The price of the stock has decreased by 15.2% since.

For the complete insider trading history of MDCO, click here.

Why CEOs Are Buying Stocks Of Their Own Companies?

1. As legendary investor Peter Lynch said: "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise."
2. TOP EXECUTIVES like CEOs and CFOs are savvy buyers of their companies' shares. One long-term study showed that they beat the market on average by six percentage points a year.
3. Another study found that the aggregated activities of insiders can serve as a good indicator to locate market bottoms. Insiders as a whole are smart investors of their own companies.

Click it to Check Out What the CEO Are Trading

More Gurufocus Links

Latest Guru Picks	Value Strategies
Warren Buffett Portfolio	Ben Graham Net-Net
Real Time Picks	Buffett-Munger Screener
Aggregated Portfolio	Undervalued Predictable
ETFs, Options	Low P/S Companies
Insider Trends	10-Year Financials
52-Week Lows	Interactive Charts
Model Portfolios	DCF Calculator
RSS Feed	Monthly Newsletters
The All-In-One Screener	Portfolio Tracking Tool